ETANERCEPT Side Effects

6428092-9 | Alopecia, Insulin Resistance, Pneumonia, Swelling Face, Weight Increased
on Oct 26, 2009 Female patient from UNITED STATES , 15 years of age, weighting 145.1 lb, was diagnosed with juvenile arthritis and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, insulin resistance, pneumonia (What is pneumonia?), swelling face, weight increased. Etanercept dosage: .

6412286-2 | Male Sexual Dysfunction, Muscle Spasms
Patient was taking Etanercept (View Usage). Patient had the following side effects: male sexual dysfunction, muscle spasms on Oct 15, 2009 from MEXICO Additional patient health information: Male patient , weighting 257.9 lb, was diagnosed with psoriasis, prophylaxis, hypertension and. Etanercept dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

6265349-9 | Sudden Hearing Loss
Adverse event was reported on Jul 09, 2009 by a Male patient taking Etanercept (View Usage) (Dosage: Twice Weekly Sq Injections/ Weekly Po Capsules In 2 Or 3 Divided Doses Separated By 12 Hours) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), antibiotic prophylaxis, hypertension, reflux oesophagitis and. Location: JAPAN , weighting 205.3 lb, After Etanercept was administered, patient had the following side effects: sudden hearing loss. During the same period patient was treated with FELBINAC (View Felbinac Review and Felbinac Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6213212-1 | Immediate Post-injection Reaction
on Jun 02, 2009 Male patient from UNITED STATES , 67 years of age, weighting 235.9 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: immediate post-injection reaction. Etanercept dosage: 50 Mg Qweek Sq.


6189380-7 | Candidiasis, Dysphagia, Extradural Abscess, Infarction, Intervertebral Discitis, Meningitis Bacterial, Mental Status Changes, Muscular Weakness
on Apr 27, 2009 Male patient from UNITED STATES , 51 years of age, was diagnosed with psoriatic arthropathy and was treated with Etanercept (View Usage). Patient had the following side effects: candidiasis, dysphagia, extradural abscess, infarction, intervertebral discitis, meningitis bacterial, mental status changes, muscular weakness. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized and became disabled.

6146731-7 | Gastrointestinal Necrosis, Small Intestinal Perforation
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: gastrointestinal necrosis, small intestinal perforation on Apr 03, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: 50 Mg Qweek Sq. Patient was hospitalized.

6129561-1 | Inflammatory Bowel Disease
Adverse event was reported on Mar 11, 2009 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with psoriasis and. Location: CANADA , weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: inflammatory bowel disease. During the same period patient was treated with CILEST (View Cilest Review and Cilest Label ), CELEXA (View Celexa Review and Celexa Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

6085000-0 | Concomitant Disease Progression, Mycosis Fungoides
on Feb 10, 2009 Male patient from CANADA , 47 years of age, was diagnosed with psoriasis, arthritis (What is arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: concomitant disease progression, mycosis fungoides. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6075091-5 | Sepsis
on Feb 10, 2009 Female patient from UNITED STATES , 72 years of age, was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: sepsis (What is sepsis?). Etanercept dosage: 50 Mg/ml.

5981503-5 | Retinal Detachment
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: retinal detachment on Nov 28, 2008 from JAPAN Additional patient health information: Male patient , weighting 92.59 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastritis prophylaxis, peripheral vascular disorder and. Etanercept dosage: . During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), TOCOPHEROL CONCENTRATE CAP (View Tocopherol Concentrate Cap Review and Tocopherol Concentrate Cap Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5944703-6 | Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Oct 30, 2008 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: JAPAN , 67 years of age, Patient had the following side effects: pneumocystis jiroveci pneumonia. During the same period patient was treated with RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), INFLIXIMAB (View Infliximab Review and Infliximab Label ).

5929317-6 | Infection In An Immunocompromised Host, Listeriosis, Meningitis Bacterial
on Oct 23, 2008 Male patient from UNITED STATES , 54 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: infection in an immunocompromised host, listeriosis, meningitis bacterial. Etanercept dosage: 50 Mg Sd Qweek.

5917295-5 | Double Stranded Dna Antibody
on Sep 30, 2008 Female patient from CROATIA (local name: Hrvatska) , 48 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), psoriatic arthropathy and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: double stranded dna antibody. Etanercept dosage: .

5886083-0 | Condition Aggravated, Liposarcoma
Patient was taking Etanercept (View Usage). Patient had the following side effects: condition aggravated, liposarcoma on Sep 02, 2008 from UNITED STATES Additional patient health information: Male patient , 73 years of age, . Etanercept dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), CALCIUM (View Calcium Review and Calcium Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

5885588-6 | Colon Cancer, Metastasis, Microcytic Anaemia
Adverse event was reported on Sep 02, 2008 by a Female patient taking Etanercept (View Usage) (Dosage: ) . Location: , 65 years of age, After Etanercept was administered, patient had the following side effects: colon cancer, metastasis, microcytic anaemia. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), CALCIUM (View Calcium Review and Calcium Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), NASAL SALINE (View Nasal Saline Review and Nasal Saline Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

5885587-4 | Renal Cell Carcinoma
on Sep 02, 2008 Female patient from UNITED STATES , 51 years of age, was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: renal cell carcinoma. Etanercept dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5885586-2 | Prostate Cancer
on Sep 02, 2008 Male patient from UNITED STATES , 70 years of age, was treated with Etanercept (View Usage). Patient had the following side effects: prostate cancer (What is prostate cancer?). Etanercept dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BACTRIM (View Bactrim Review and Bactrim Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), AVANDIA (View Avandia Review and Avandia Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5885583-7 | Gallbladder Cancer, Metastases To Bone, Metastases To Liver, Metastases To Lung, Metastasis, Refusal Of Treatment By Patient
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: gallbladder cancer (What is gallbladder cancer?), metastases to bone, metastases to liver, metastases to lung, metastasis, refusal of treatment by patient on Sep 02, 2008 from UNITED STATES Additional patient health information: Male patient , 60 years of age, . Etanercept dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

5885582-5 | Colon Cancer, Microcytic Anaemia
Adverse event was reported on Sep 02, 2008 by a Female patient taking Etanercept (View Usage) (Dosage: ) . Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: colon cancer, microcytic anaemia. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), MEPRON (View Mepron Review and Mepron Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

5883769-9 | Pneumocystis Jiroveci Pneumonia
on Sep 01, 2008 Female patient from KOREA, REPUBLIC OF , weighting 98.99 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), prophylaxis, hypothyroidism and was treated with Etanercept (View Usage). Patient had the following side effects: pneumocystis jiroveci pneumonia. Etanercept dosage: . During the same period patient was treated with MISOPROSTOL (View Misoprostol Review and Misoprostol Label ), FOLATE SODIUM (View Folate Sodium Review and Folate Sodium Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5862785-7 | Disseminated Intravascular Coagulation
on Aug 22, 2008 Female patient from UNITED STATES , weighting 162.0 lb, was diagnosed with hepatitis alcoholic and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: disseminated intravascular coagulation. Etanercept dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), VICON FORTE (View Vicon Forte Review and Vicon Forte Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ). Patient was hospitalized.

5862776-6 | Escherichia Urinary Tract Infection
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: escherichia urinary tract infection on Aug 22, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 176.1 lb, was diagnosed with hepatitis alcoholic and. Etanercept dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), ALLEGRA (View Allegra Review and Allegra Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ). Patient was hospitalized.

5838806-4 | Retinal Detachment
Adverse event was reported on Jul 30, 2008 by a Male patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), gastritis prophylaxis, peripheral vascular disorder and. Location: JAPAN , weighting 92.59 lb, Patient had the following side effects: retinal detachment. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), TOCOPHEROL CONCENTRATE CAP (View Tocopherol Concentrate Cap Review and Tocopherol Concentrate Cap Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5754273-3 | Back Pain, Dyspnoea
on May 20, 2008 Female patient from UNITED STATES , weighting 167.6 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: back pain (What is back pain?), dyspnoea. Etanercept dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM CITRATE (View Calcium Citrate Review and Calcium Citrate Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), EVOXAC (View Evoxac Review and Evoxac Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

5708669-6 | Atrial Fibrillation
on Apr 04, 2008 Female patient from UNITED STATES , 80 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?). Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5644225-6 | Injection Site Irritation
Patient was taking Etanercept (View Usage). Patient had the following side effects: injection site irritation on Feb 27, 2008 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: 25mg Other Sq.

5536022-7 | Lymphatic Disorder
Adverse event was reported on Nov 23, 2007 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , 42 years of age, weighting 200.6 lb, After Etanercept was administered, patient had the following side effects: lymphatic disorder.

5357004-4 | Pleural Effusion, Rheumatoid Arthritis
on Jun 12, 2007 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion, rheumatoid arthritis (What is rheumatoid arthritis?). Etanercept dosage: 50mg Weekly Subcut.. During the same period patient was treated with METHOTREXATE (12.5 Mg Weekly Oral) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5337520-1 | Acid Fast Bacilli Infection, Adenoviral Upper Respiratory Infection, Lupus Pneumonitis, Pleural Effusion, Systemic Lupus Erythematosus, Thrombocytopenia
on May 15, 2007 Female patient from KOREA, REPUBLIC OF , 55 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: acid fast bacilli infection, adenoviral upper respiratory infection, lupus pneumonitis, pleural effusion, systemic lupus erythematosus, thrombocytopenia. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NSAIDS (View Nsaids Review and Nsaids Label ).

5325381-6 | Pulmonary Sarcoidosis
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: pulmonary sarcoidosis on May 01, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 52 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: .

5324934-9 | Crohn's Disease
Adverse event was reported on May 03, 2007 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with juvenile arthritis and. Location: UNITED STATES , weighting 57.54 lb, Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLATE SODIUM (View Folate Sodium Review and Folate Sodium Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), MIRALAX (View Miralax Review and Miralax Label ), REMICADE (View Remicade Review and Remicade Label ).

5321118-5 | Mobility Decreased, Post Procedural Infection, Surgery
on Apr 30, 2007 Female patient from UNITED KINGDOM , weighting 183.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: mobility decreased, post procedural infection, surgery (What is surgery?). Etanercept dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

5318729-X | Anaemia, Leukopenia, Neutropenia, Thrombocytopenia
on May 03, 2007 Male patient from UNITED STATES , 16 years of age, was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: anaemia, leukopenia, neutropenia, thrombocytopenia. Etanercept dosage: .

5318226-1 | Polycystic Ovaries
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: polycystic ovaries on Apr 23, 2007 from UNITED KINGDOM Additional patient health information: Female patient , weighting 112.9 lb, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Etanercept dosage: .

5292325-5 | Thrombocytopenia, Viral Infection
Adverse event was reported on Mar 30, 2007 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with psoriatic arthropathy and. Location: UNITED KINGDOM , weighting 79.37 lb, Patient had the following side effects: thrombocytopenia, viral infection (What is viral infection?). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

5287920-3 | Crohn's Disease
on Mar 22, 2007 Female patient from UNITED STATES , weighting 57.54 lb, was diagnosed with juvenile arthritis and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: crohn's disease (What is crohn's disease?). Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), FOLATE SODIUM (View Folate Sodium Review and Folate Sodium Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), MIRALAX (View Miralax Review and Miralax Label ), REMICADE (View Remicade Review and Remicade Label ).

5280079-8 | Progressive Multifocal Leukoencephalopathy
on Mar 15, 2007 Female patient from JAPAN , 74 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), antibiotic prophylaxis and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. Etanercept dosage: . During the same period patient was treated with RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ). Patient was hospitalized.

5260738-3 | Abortion Spontaneous
Patient was taking Etanercept (View Usage). Patient had the following side effects: abortion spontaneous on Mar 20, 2006 from Additional patient health information: Female patient , 26 years of age, was diagnosed with psoriasis and. Etanercept dosage: .

5254081-6 | Pneumonia, Respiratory Failure, Septic Shock, Streptococcal Identification Test Positive
Adverse event was reported on Feb 15, 2007 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with psoriatic arthropathy and. Location: UNITED STATES , 65 years of age, After Etanercept was administered, patient had the following side effects: pneumonia (What is pneumonia?), respiratory failure, septic shock, streptococcal identification test positive. Patient was hospitalized.

5242319-0 | Neutropenia
on Feb 16, 2007 Male patient from UNITED STATES , 56 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Etanercept dosage: 25 Mg Twice Weekly. During the same period patient was treated with LEFLUNOMIDE (10 Mg Qd) (View Leflunomide Review and Leflunomide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized.

5237699-6 | Gliosarcoma, Lung Neoplasm Malignant, Meningioma Benign
on Feb 08, 2007 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient had the following side effects: gliosarcoma, lung neoplasm malignant, meningioma benign. Etanercept dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), ZESTRIL (View Zestril Review and Zestril Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), PROCARDIA (View Procardia Review and Procardia Label ), DETROL (View Detrol Review and Detrol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

5236958-0 | Lymphadenitis, Tuberculosis
Patient was taking Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: lymphadenitis, tuberculosis (What is tuberculosis?) on Jan 29, 2007 from IRELAND Additional patient health information: Male patient , 36 years of age, was diagnosed with psoriasis and. Etanercept dosage: .

5234909-6 | Macrocytosis
Adverse event was reported on Jan 26, 2007 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED KINGDOM , weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: macrocytosis. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

5228476-0 | Myelodysplastic Syndrome
on Jan 22, 2007 Male patient from UNITED KINGDOM , 57 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Etanercept (View Usage). Patient had the following side effects: myelodysplastic syndrome. Etanercept dosage: . During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ).

5224066-4 | Gliosarcoma, Lung Neoplasm Malignant, Meningioma Benign
on Jan 16, 2007 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: gliosarcoma, lung neoplasm malignant, meningioma benign. Etanercept dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), ZESTRIL (View Zestril Review and Zestril Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), PROCARDIA (View Procardia Review and Procardia Label ), DETROL (View Detrol Review and Detrol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

5210530-0 | Carcinoid Tumour
Patient was taking Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: carcinoid tumour on Jan 05, 2007 from TURKEY Additional patient health information: Male patient , 21 years of age, was diagnosed with spondylitis, antibiotic prophylaxis and. Etanercept dosage: . During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5194853-X | Acid Fast Bacilli Infection, Adenoviral Upper Respiratory Infection, Blood Albumin Decreased, Lupus Pneumonitis, Pleural Effusion, Pneumonia, Pulmonary Haemorrhage, Systemic Lupus Erythematosus, Thrombocytopenia
Adverse event was reported on Nov 30, 2006 by a Female patient taking Etanercept (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: KOREA, REPUBLIC OF , 55 years of age, Patient had the following side effects: acid fast bacilli infection, adenoviral upper respiratory infection, blood albumin decreased, lupus pneumonitis, pleural effusion, pneumonia (What is pneumonia?), pulmonary haemorrhage, systemic lupus erythematosus, thrombocytopenia. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NSAIDS (View Nsaids Review and Nsaids Label ).

5187498-9 | Condition Aggravated, Guttate Psoriasis
on Apr 05, 2006 Female patient from UNITED STATES , child 12 years of age, was diagnosed with psoriasis and was treated with Etanercept (View Usage). After Etanercept was administered, patient had the following side effects: condition aggravated, guttate psoriasis. Etanercept dosage: .

5183193-0 | Gliosarcoma, Lung Neoplasm Malignant, Meningioma Benign
on Nov 14, 2006 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Etanercept (View Usage). Patient experienced the following unwanted or unexpected effects: gliosarcoma, lung neoplasm malignant, meningioma benign. Etanercept dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), ZESTRIL (View Zestril Review and Zestril Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), PROCARDIA (View Procardia Review and Procardia Label ), DETROL (View Detrol Review and Detrol Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

5174090-5 | Acid Fast Bacilli Infection, Adenoviral Upper Respiratory Infection, Anaemia, Cachexia, Gingival Bleeding, Lung Infiltration, Mouth Ulceration, Pleural Effusion, Pneumonitis
Patient was taking Etanercept (View Usage). Patient had the following side effects: acid fast bacilli infection, adenoviral upper respiratory infection, anaemia, cachexia, gingival bleeding, lung infiltration, mouth ulceration, pleural effusion, pneumonitis on Nov 30, 2006 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 55 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Etanercept dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), NSAIDS (View Nsaids Review and Nsaids Label ).